Eli Lilly Just Announced a Major Acquisition. Here's What It Means.
The drug giant added to its immunotherapy portfolio.
The drug giant added to its immunotherapy portfolio.
BELLINGS Intelligence Score: 18
Why it matters
Eli Lilly's acquisition is a routine corporate expansion within the pharmaceutical sector, unlikely to materially affect credit markets or underwriting standards beyond the company and its immediate investors.